Consequently, various groups have developed strategies to overexpress SDF-1 mRNA or deliver SDF-1 protein after acute myocardial infarction in the heart to attenuate ischemic cardiomyopathy [7–9]. Here, CXCL12 is linked to ischemic cardiomyopathy.